• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏病病房中出现药物相关问题的患者风险因素。

Patient risk factors for developing a drug-related problem in a cardiology ward.

作者信息

Urbina Olatz, Ferrández Olivia, Luque Sònia, Grau Santiago, Mojal Sergi, Pellicer Rosa, Riu Marta, Salas Esther, Comin-Colet Josep

机构信息

Pharmacy Department, Hospital Universitari del Mar, Barcelona, Spain.

Pharmacy Department, Hospital Universitari del Mar, Barcelona, Spain ; Universitat Autònoma de Barcelona, Barcelona, Spain.

出版信息

Ther Clin Risk Manag. 2014 Dec 17;11:9-15. doi: 10.2147/TCRM.S71749. eCollection 2015.

DOI:10.2147/TCRM.S71749
PMID:25565852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4275111/
Abstract

BACKGROUND

Because of the high incidence of drug-related problems (DRPs) among hospitalized patients with cardiovascular diseases and their potential impact on morbidity and mortality, it is important to identify the most susceptible patients, who therefore require closer monitoring of drug therapy.

PURPOSE

To identify the profile of patients at higher risk of developing at least one DRP during hospitalization in a cardiology ward.

METHOD

We consecutively included all patients hospitalized in the cardiology ward of a teaching hospital in 2009. DRPs were identified through a computerized warning system designed by the pharmacy department and integrated into the electronic medical record.

RESULTS

A total of 964 admissions were included, and at least one DRP was detected in 29.8%. The variables associated with a higher risk of these events were polypharmacy (odds ratio [OR]=1.228; 95% confidence interval [CI]=1.153-1.308), female sex (OR=1.496; 95% CI=1.026-2.180), and first admission (OR=1.494; 95% CI=1.005-2.221).

CONCLUSION

Monitoring patients through a computerized warning system allowed the detection of at least one DRP in one-third of the patients. Knowledge of the risk factors for developing these problems in patients admitted to hospital for cardiovascular problems helps in identifying the most susceptible patients.

摘要

背景

由于心血管疾病住院患者中药物相关问题(DRP)的发生率较高,且这些问题对发病率和死亡率有潜在影响,因此识别最易受影响的患者很重要,这些患者需要更密切地监测药物治疗。

目的

确定在心脏病病房住院期间发生至少一种DRP风险较高的患者特征。

方法

我们连续纳入了2009年在一家教学医院心脏病病房住院的所有患者。通过药房设计并整合到电子病历中的计算机化预警系统识别DRP。

结果

共纳入964例住院患者,其中29.8%检测到至少一种DRP。与这些事件风险较高相关的变量包括用药种类多(比值比[OR]=1.228;95%置信区间[CI]=1.153 - 1.308)、女性(OR=1.496;95% CI=1.026 - 2.180)和首次住院(OR=1.494;95% CI=1.005 - 2.221)。

结论

通过计算机化预警系统对患者进行监测,可在三分之一的患者中检测到至少一种DRP。了解心血管疾病住院患者发生这些问题的风险因素有助于识别最易受影响的患者。

相似文献

1
Patient risk factors for developing a drug-related problem in a cardiology ward.心脏病病房中出现药物相关问题的患者风险因素。
Ther Clin Risk Manag. 2014 Dec 17;11:9-15. doi: 10.2147/TCRM.S71749. eCollection 2015.
2
Design of a score to identify hospitalized patients at risk of drug-related problems.用于识别有药物相关问题风险的住院患者的评分系统设计。
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):923-32. doi: 10.1002/pds.3634. Epub 2014 May 10.
3
Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period.一项用于识别4年期间有药物相关问题风险的住院患者的评分系统的验证。
Saudi Pharm J. 2018 Jul;26(5):703-708. doi: 10.1016/j.jsps.2018.02.020. Epub 2018 Feb 8.
4
Computerized pharmacy surveillance and alert system for drug-related problems.用于药物相关问题的计算机化药房监测与警报系统。
J Clin Pharm Ther. 2017 Apr;42(2):201-208. doi: 10.1111/jcpt.12495. Epub 2017 Jan 12.
5
Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey.土耳其内科病房临床药师发现的药物相关问题。
Int J Clin Pharm. 2018 Apr;40(2):360-367. doi: 10.1007/s11096-017-0585-5. Epub 2018 Jan 29.
6
Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic.2019年冠状病毒病大流行期间因感染严重急性呼吸综合征冠状病毒2而入院患者的药物相关问题。
Front Pharmacol. 2022 Nov 24;13:993158. doi: 10.3389/fphar.2022.993158. eCollection 2022.
7
Drug-related problems identified by pharmacist-led medication review in Slovak hospitalised patients.斯洛伐克住院患者中由药剂师主导的药物评估所识别出的药物相关问题。
Pharmazie. 2016 Sep 1;71(9):548-551. doi: 10.1691/ph.2016.5760.
8
Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.巴西一家三级教学医院神经内科临床药师干预分析。
PLoS One. 2019 Jan 18;14(1):e0210779. doi: 10.1371/journal.pone.0210779. eCollection 2019.
9
A prospective study of incidence of medication-related problems in general medicine ward of a tertiary care hospital.一项关于三级医院普通内科病房药物相关问题发生率的前瞻性研究。
J Adv Pharm Technol Res. 2015 Oct-Dec;6(4):190-4. doi: 10.4103/2231-4040.166502.
10
Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia.埃塞俄比亚贡德尔大学医院心血管疾病患者发生药物相关问题的危险因素。
J Pharm Bioallied Sci. 2016 Oct-Dec;8(4):289-295. doi: 10.4103/0975-7406.199335.

引用本文的文献

1
Drug therapy problems among hospitalized patients with cardiovascular disease.住院心血管疾病患者的药物治疗问题。
BMC Cardiovasc Disord. 2024 Jan 15;24(1):50. doi: 10.1186/s12872-024-03710-8.
2
Medication Related-Problems and Associated Factors Among Patients with Hypertension at a Tertiary Care Hospital in Ethiopia: A Prospective Interventional Study.埃塞俄比亚一家三级护理医院高血压患者的药物相关问题及相关因素:一项前瞻性干预研究。
Integr Blood Press Control. 2023 Nov 30;16:123-136. doi: 10.2147/IBPC.S434072. eCollection 2023.
3
Impact of medication therapy management interventions on drug therapy problems, medication adherence and treatment satisfaction among ambulatory heart failure patients at Tikur Anbessa Specialised Hospital, Addis Ababa, Ethiopia: a one-group pre-post quasi-experimental study.在提克里安贝萨专科医院,埃塞俄比亚亚的斯亚贝巴,药物治疗管理干预对门诊心力衰竭患者的药物治疗问题、药物依从性和治疗满意度的影响:一项单组前后准实验研究。
BMJ Open. 2022 Apr 12;12(4):e054913. doi: 10.1136/bmjopen-2021-054913.
4
Drug-Related Problems Among Ambulatory Heart Failure Patients on Follow-Up at Debre Berhan Comprehensive Specialized Hospital, Ethiopia.埃塞俄比亚德布雷伯尔汉综合专科医院门诊心力衰竭患者随访期间的药物相关问题
Ther Clin Risk Manag. 2021 Nov 10;17:1165-1175. doi: 10.2147/TCRM.S337256. eCollection 2021.
5
Medication-related adverse events in health care-what have we learned? A narrative overview of the current knowledge.医疗保健中的药物相关不良事件——我们学到了什么?当前知识的叙述性概述。
Eur J Clin Pharmacol. 2022 Feb;78(2):159-170. doi: 10.1007/s00228-021-03213-x. Epub 2021 Oct 6.
6
"Childrens are not just "little adults". The rate of medication related problems and its predictors among patients admitted to pediatric ward of southwestern Ethiopian hospital: A prospective observational study.儿童并非只是“小大人”。埃塞俄比亚西南部医院儿科病房患者中与用药相关问题的发生率及其预测因素:一项前瞻性观察研究。
Ann Med Surg (Lond). 2021 Sep 7;70:102827. doi: 10.1016/j.amsu.2021.102827. eCollection 2021 Oct.
7
Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚与药物相关的问题及相关因素:一项系统评价与荟萃分析
J Pharm Policy Pract. 2021 Apr 26;14(1):36. doi: 10.1186/s40545-021-00312-z.
8
Magnitude and determinants of drug-related problems among patients admitted to medical wards of southwestern Ethiopian hospitals: A multicenter prospective observational study.西南埃塞俄比亚医院内科病房患者药物相关问题的严重程度及其决定因素:一项多中心前瞻性观察研究。
PLoS One. 2021 Mar 16;16(3):e0248575. doi: 10.1371/journal.pone.0248575. eCollection 2021.
9
Evaluation of drug therapy problems, medication adherence and treatment satisfaction among heart failure patients on follow-up at a tertiary care hospital in Ethiopia.评估埃塞俄比亚一家三级保健医院心力衰竭患者随访中的药物治疗问题、药物依从性和治疗满意度。
PLoS One. 2020 Aug 28;15(8):e0237781. doi: 10.1371/journal.pone.0237781. eCollection 2020.
10
Risk factors for drug-related problems in a general hospital: A large prospective cohort.综合医院药物相关问题的风险因素:一项大型前瞻性队列研究。
PLoS One. 2020 May 5;15(5):e0230215. doi: 10.1371/journal.pone.0230215. eCollection 2020.

本文引用的文献

1
Design of a score to identify hospitalized patients at risk of drug-related problems.用于识别有药物相关问题风险的住院患者的评分系统设计。
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):923-32. doi: 10.1002/pds.3634. Epub 2014 May 10.
2
A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease.临床药师干预对心血管疾病二级预防的临床及经济效果的系统评价
J Manag Care Pharm. 2013 Jun;19(5):408-16. doi: 10.18553/jmcp.2013.19.5.408.
3
Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.心力衰竭的临床药学服务:美国心力衰竭学会和美国临床药学学院心脏病学实践与研究网络的意见文件。
Pharmacotherapy. 2013 May;33(5):529-48. doi: 10.1002/phar.1295.
4
Strategies to reduce the risk of iatrogenic illness in complex older adults.减少复杂老年患者医源性疾病风险的策略。
Age Ageing. 2013 May;42(3):284-91. doi: 10.1093/ageing/aft038. Epub 2013 Mar 28.
5
Drug-related problems and hospital admissions in cardiac transplant recipients.心脏移植受者的药物相关问题和住院治疗。
Ann Pharmacother. 2012 Oct;46(10):1299-307. doi: 10.1345/aph.1R094. Epub 2012 Oct 2.
6
Global cardiovascular disease prevention: a call to action for nursing executive summary.全球心血管疾病预防:护理行动呼吁 执行摘要。
J Cardiovasc Nurs. 2013 Nov-Dec;28(6):505-13. doi: 10.1097/JCN.0b013e31826b6822.
7
ASHP guidelines on pharmacy planning for implementation of computerized provider-order-entry systems in hospitals and health systems.美国卫生系统药师协会关于医院和卫生系统实施计算机医嘱录入系统的药房规划指南。
Am J Health Syst Pharm. 2011 Mar 15;68(6):e9-31. doi: 10.2146/sp100011e.
8
Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic.与心力衰竭(HF)门诊患者药物相关问题相关的负面临床结局:多学科 HF 诊所中一名药剂师的影响。
J Card Fail. 2011 Mar;17(3):217-23. doi: 10.1016/j.cardfail.2010.10.009. Epub 2010 Dec 24.
9
Trends in comorbidity, disability, and polypharmacy in heart failure.心力衰竭合并症、残疾和多药治疗的趋势。
Am J Med. 2011 Feb;124(2):136-43. doi: 10.1016/j.amjmed.2010.08.017.
10
Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score.65岁及以上住院患者药物不良反应风险评估评分的开发与验证:老年医学网络药物不良反应风险评分
Arch Intern Med. 2010 Jul 12;170(13):1142-8. doi: 10.1001/archinternmed.2010.153.